)
Owens & Minor (OMI) investor relations material
Owens & Minor Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Announced definitive agreement to sell the Products & Healthcare Services (P&HS) segment to Platinum Equity for $375 million, retaining an equity interest, with the transaction expected to close in Q1 2026.
Strategic shift positions the company as a pure-play home-based care business, focusing on the Patient Direct platform and long-term growth.
Nationwide preferred provider agreements, including a new deal with Optum, are expected to drive organic growth in home-based care.
Financial results were impacted by a $80 million transaction breakage fee and $18 million in transaction financing fees due to the terminated Rotech acquisition.
Forward-looking statements reflect expectations for 2025 performance, including cost-saving initiatives and the anticipated segment sale.
Financial highlights
Q3 2025 revenue from continuing operations was $697.3 million, up from $686.8 million in Q3 2024.
Adjusted EBITDA for Q3 2025 was $92.2 million, down from $107.7 million in Q3 2024; year-to-date adjusted EBITDA was $285 million, up 6.3%.
Adjusted net income per share for Q3 2025 was $0.25, compared to $0.36 in Q3 2024; year-to-date adjusted net income per share was $0.80 versus $0.64 last year.
Basic and diluted loss per share from continuing operations was $(0.07) for Q3 2025.
Net loss from discontinued operations was $145 million for Q3 2025, driven by goodwill impairment and loss on classification to held for sale.
Outlook and guidance
Reaffirmed 2025 full-year guidance: revenue between $2.76–$2.82 billion, adjusted net income $1.02–$1.07 per share, and adjusted EBITDA $376–$382 million.
Full-year revenue expected toward the bottom of the guidance range due to updated interest expense allocation.
2026 guidance not yet published; expect to provide details with Q4 results.
The sale of the P&HS segment is expected to close in Q1 2026, with proceeds intended to repay $280 million in debt and focus on Patient Direct.
Anticipates strong 2026 performance, with the loss of a large, low-margin customer contract offset by improved margins and cash flow.
Next Owens & Minor earnings date
Next Owens & Minor earnings date
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)